A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)

L. Burt Nabors, Thomas Mikkelsen, Monika E. Hegi, Xiaubu Ye, Tracy Batchelor, Glenn Lesser, David Peereboom, Myrna R. Rosenfeld, Jeff Olsen, Steve Brem, Joy D. Fisher, Stuart A. Grossman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)'. Together they form a unique fingerprint.

Medicine & Life Sciences